Generex trades higher on positive vaccine results
December 15, 2009 06:13 AM
E-mail|
|Comments
()|
Text size
–
+
WORCESTER -- Biotech drugmaker Generex Biotechnology Corp. yesterday reported positive results for a mid-stage study of its experimental cancer vaccine.
The company said data after 13 months showed only half of breast cancer patients who received the company's vaccine relapsed, compared with those not taking the vaccine. Generex will report the final results after two years of follow-up. The company is also studying the vaccine to prevent relapse in prostate cancer patients.
Shares of Generex rose 5 cents, or 7.8 percent, to 68 cents in afterhours trading.
Comment
Permalink
E-mail
